Literature DB >> 8809878

Iron-induced tissue damage and cancer: the role of reactive oxygen species-free radicals.

S Okada1.   

Abstract

Oxygen is poisonous, but we cannot live without it. The high oxidizing potential of oxygen molecules (dioxygen) is a valuable source of energy for the organism and its reactivity is low; that is, spin forbidden. However, the dioxygen itself is a 'free radical' and, especially in the presence of transition metals, it is a major promoter of radical reactions in the cell. Humans survive only by virtue of their elaborate defense mechanisms against oxygen toxicity. Iron is the most abundant transition metal in the human body. Because iron shows wide variation in redox potential with different co-ordination ligands, it may be used as a redox intermediate in many biological mechanism. However, it is precisely this redox activeness that makes iron a key participant in free radical production. The current research on the relationship between iron and cancer is briefly reviewed. Research results are reported here which indicate that iron, when bound to certain ligands, can cause free-radical mediated tissue damage and become carcinogenic. The present study also suggests that iron may also have a significant role in spontaneous human cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8809878     DOI: 10.1111/j.1440-1827.1996.tb03617.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  37 in total

1.  Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet.

Authors:  Jaya R P Prasanthi; Matthew Schrag; Bhanu Dasari; Gurdeep Marwarha; April Dickson; Wolff M Kirsch; Othman Ghribi
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Iron toxicity and chelation therapy.

Authors:  Robert S Britton; Katherine L Leicester; Bruce R Bacon
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

3.  Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress.

Authors:  T Tanaka; S Kondo; Y Iwasa; H Hiai; S Toyokuni
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

Review 4.  The Many Virtues of tRNA-derived Stress-induced RNAs (tiRNAs): Discovering Novel Mechanisms of Stress Response and Effect on Human Health.

Authors:  Mridusmita Saikia; Maria Hatzoglou
Journal:  J Biol Chem       Date:  2015-10-13       Impact factor: 5.157

Review 5.  Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis.

Authors:  Shinya Toyokuni
Journal:  Redox Rep       Date:  2013-11-20       Impact factor: 4.412

6.  Modulatory effects of Pluchea lanceolata against chemically induced oxidative damage, hyperproliferation and two-stage renal carcinogenesis in Wistar rats.

Authors:  Tamanna Jahangir; Sarwat Sultana
Journal:  Mol Cell Biochem       Date:  2006-06-10       Impact factor: 3.396

7.  Quantitation of Apurinic/Apyrimidinic Sites in Isolated DNA and in Mammalian Tissue with a Reduced Level of Artifacts.

Authors:  Haoqing Chen; Lihua Yao; Christina Brown; Carmelo J Rizzo; Robert J Turesky
Journal:  Anal Chem       Date:  2019-05-13       Impact factor: 6.986

8.  Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview.

Authors:  D Metodiewa; C Kośka
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

9.  A beverage containing fermented black soybean ameliorates ferric nitrilotriacetate-induced renal oxidative damage in rats.

Authors:  Yasumasa Okazaki; Mohammad Iqbal; Norito Kawakami; Yorihiro Yamamoto; Shinya Toyokuni; Shigeru Okada
Journal:  J Clin Biochem Nutr       Date:  2010-09-16       Impact factor: 3.114

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.